Weiwei Liu

888 total citations
38 papers, 750 citations indexed

About

Weiwei Liu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Weiwei Liu has authored 38 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Cell Biology. Recurrent topics in Weiwei Liu's work include MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (5 papers). Weiwei Liu is often cited by papers focused on MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (5 papers). Weiwei Liu collaborates with scholars based in China, Japan and Macao. Weiwei Liu's co-authors include Bei Shi, Ranzun Zhao, Yan Wang, Junbo Ge, Zhenglong Wang, Chaofu Li, Changyin Shen, Xianping Long, Wei Zhang and Qiuliang Wu and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Microbiology and Biosensors and Bioelectronics.

In The Last Decade

Weiwei Liu

35 papers receiving 743 citations

Peers

Weiwei Liu
Comparison fields: 5 of 80
  • Molecular Biology 569
  • Cancer Research 357
  • Cardiology and Cardiovascular Medicine 88
  • Oncology 61
  • Immunology 59
Replace Jiaming Ju with:
Jiaming Ju China
Qianhui Li China
Yiwen Zhang China
Grażyna Kubiak-Tomaszewska Poland
Mengyao Sun China
Jingjuan Huang China
Jiaming Ju China View profile →
Citations per field, relative to Weiwei Liu
Weiwei Liu · 1×
Citations per year, relative to Weiwei Liu
Weiwei Liu · 1×

Countries citing papers authored by Weiwei Liu

Since Specialization
Citations

This map shows the geographic impact of Weiwei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Liu more than expected).

Fields of papers citing papers by Weiwei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Liu. The network helps show where Weiwei Liu may publish in the future.

Co-authorship network of co-authors of Weiwei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Liu. A scholar is included among the top collaborators of Weiwei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Liu. Weiwei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 1
4 0
5 0
6 3
7 6
8 107
9 26
10 16
11 39
12 15
13 26
14 12
15 5
16 1
17 53
18
Effect of Yin-Qiao-Jie-Du Pill on β-defensin1's Expression in Lung Tissue of Mice Infected With Influenza A Virus
1
19 24
20 51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026